Beautiful Virgin Islands

Monday, Jun 30, 2025

China's fourth COVID-19 vaccine enters clinical trial stage

China's fourth COVID-19 vaccine enters clinical trial stage

China's fourth COVID-19 vaccine entered clinical trials on Tuesday in central China's Henan province. The vaccine is developed by the National Institute of Vaccines and Serums under the China National Biotechnology Group (CNBG).
This is the second inactivated COVID-19 vaccine that CNBC has developed and has been approved by the China National Administration of Medical Products for its clinical trials. The country's first inactivated COVID-19 vaccine has already entered the second phase of clinical trials on Friday.

Since the outbreak of the new coronavirus, the CNBG has allocated 1 billion yuan ($141.29 million) to develop vaccines against COVID-19 at three of its research institutes along two technical routes.

“It usually takes several years to research and develop a vaccine. But we have been working shifts throughout the day, which shortens the time. This also demonstrates the strength and speed of China, "said Wang Hui, president of the National Institute of Vaccines and Serum.

Wang said the research team has conquered a number of key technologies in vaccine production and quality control, and has conducted three clinical samples of high, moderate and low doses. The vaccine will not be released until the third phase of clinical trials is completed.

The CNBG has built the world's largest COVID-19 vaccine laboratory in Beijing, with a designed production capacity of 100 million doses each year, capable of meeting the demand for large-scale emergency use and routine vaccination. .

“It took 78 days to build the laboratory from site selection to completion of construction, while the actual construction period was only about 60 days. This is the first high-level biosafety protection laboratory for human use in China, ”said Dong Jianchun, head of the engineering support department of the National Institute of Vaccines and Serum.

"Once the laboratory is created, in accordance with the law and with the approval of the relevant state departments, the vaccine produced in it could serve special groups of people, such as medical professionals, diplomats, construction workers of the Strip and Route, and students abroad, "said Zhu Jingjin, head of the CNBG.
Newsletter

Related Articles

Beautiful Virgin Islands
0:00
0:00
Close
Texas Enacts Law Allowing Gold and Silver Transactions
China Unveils Miniature Insect-Like Surveillance Drone
OpenAI Secures Multimillion-Dollar AI Contracts with Pentagon, India, and Grab
Marc Marquez Claims Victory at Dutch Grand Prix Amidst Family Misfortune
Germany Votes to Suspend Family Reunification for Asylum Seekers
Elon Musk Critiques Senate Budget Proposal Over Job Losses and Strategic Risks
Los Angeles Riots ended with Federal Investigations into Funding
Budapest Pride Parade Draws 200,000 Participants Amid Government Ban
Southern Europe Experiences Extreme Heat
Xiaomi's YU7 SUV Launch Garners Record Pre-Orders Amid Market Challenges
Jeff Bezos and Lauren Sanchez's Lavish Wedding in Venice
Russia Launches Largest Air Assault on Ukraine Since Invasion
Education Secretary Announces Overhaul of Complaints System Amid Rising Parental Grievances
Massive Anti-Government Protests Erupt in Belgrade
Trump Ends Trade Talks with Canada Over Digital Services Tax
UK Government Softens Welfare Reform Plans Amid Labour Party Rebellion
Labour Faces Rebellion Over Disability Benefit Reforms Ahead of Key Vote
Jeff Bezos and Lauren Sánchez Host Lavish Wedding in Venice Amid Protests
Trump Asserts Readiness for Further Strikes on Iran Amid Nuclear Tensions
North Korea to Open New Beach Resort to Boost Tourism Economy
UK Labour Party Faces Internal Tensions Over Welfare Reforms
Andrew Cuomo Hints at Potential November Comeback Amid Democratic Primary Results
Curtis Sliwa Champions His Vision for New York City Amid Rising Crime Concerns
Federal Reserve Proposes Changes to Capital Rule Affecting Major Banks
EU TO HUNGARY: LET THEM PRIDE OR PREP FOR SHADE. ORBÁN TO EU: STAY IN YOUR LANE AND FIX YOUR OWN MESS.
Trump Escalates Criticism of Media Over Iran Strike Coverage
Trump Announces Upcoming US-Iran Meeting Amid Controversial Airstrikes
Trump Moves to Reshape Middle East Following Israel-Iran Conflict
Big Four Accounting Firms Fined in Exam Cheating Scandal
NATO Members Agree to 5% Defense Spending Target by 2035
Australia's Star Casino Secures $195 Million Rescue Package Amid Challenges
UK to Enhance Nuclear Capabilities with Acquisition of F-35A Fighter Jets
Russian Shadow Payments via Cryptocurrency Reach $9 Billion
Explosions Rock Doha as Iranian Missiles Target Qatar
“You Have 12 Hours to Flee”: Israeli Threat Campaign Targets Surviving Iranian Officials
Macron and Merz: Europe must arm itself in an unstable world
Germany and Italy Under Pressure to Repatriate $245bn of Gold from US Vaults
Airlines Evaluate Flight Cancellations Amid Escalating US-Iran Tensions
Starmer Invites Innovators to Join Government Talent Scheme
UK Economy’s Strong Opening Quarter Shows Signs of Cooling
Harrods Seeks Court Order to Secure Al Fayed Estate for Victims
BA and Singapore Airlines Cancel Dubai Flights Amid Middle East Tensions
Trump Faces Backlash from MAGA Base Over Iran Strikes
Meta Bets $14 B on Alexandr Wang to Drive AI Ambitions
WATCH: Israeli forces show the aftermath of a massive airstrike at Iran's Isfahan nuclear site
FedEx Founder Fred Smith, ‘Heart and Soul’ of the Company, Dies at 80
Chinese Factories Shift Away from U.S. Amid Trump‑Era Tariffs
Pimco Seizes Opportunity in Japan’s Dislocated Bond Market
Labubu Doll Drives Pop Mart to Status as China’s Most Valuable Toy Maker
Global Coal Demand Defies Paris Accord Goals
×